Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Boster

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|May 26, 2009
Pharmacotherapy of multiple sclerosis: the PROOF trialAaron Boster, Michael K Racke
Neurology|June 17, 2009
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialOmar A Khan, Alexandros Tselis, Aaron Boster
Drugs|December 15, 2010
The potential role of B cell-targeted therapies in multiple sclerosisAaron Boster, Daniel P Ankeny, Michael K Racke
Therapeutic Advances in Neurological Disorders|October 20, 2011
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosisAaron Boster, Mary Pat Bartoszek, Colleen O'Connell, et al.
Journal of the International Neuropsychological Society : JINS|November 2, 2011
Physical activity associated with increased resting-state functional connectivity in multiple sclerosisRuchika Shaurya Prakash, Beth Patterson, Alisha Janssen, et al.
Journal of Clinical and Experimental Neuropsychology|April 8, 2015
The effects of video-game training on broad cognitive transfer in multiple sclerosis: A pilot randomized controlled trialAlisha Janssen, Aaron Boster, HyunKyu Lee, et al.
Neurology. Clinical Practice|February 15, 2018
Managing loss of intrathecal baclofen efficacy: Review of the literature and proposed troubleshooting algorithmAaron Boster, Jacqueline Nicholas, Mary Pat Bartoszek, et al.
Neurology. Clinical Practice|March 13, 2019
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologistEdward J Fox, Guy J Buckle, Barry Singer, et al.
Neuropsychologia|August 27, 2013
Resting-state functional connectivity in multiple sclerosis: an examination of group differences and individual differencesAlisha L Janssen, Aaron Boster, Beth A Patterson, et al.
The Lancet. Neurology|February 20, 2019
Intracerebral haemorrhage during alemtuzumab administrationChristina J Azevedo, Christen Kutz, Amy Dix, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|May 26, 2009
Pharmacotherapy of multiple sclerosis: the PROOF trialAaron Boster, Michael K Racke
Neurology|June 17, 2009
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialOmar A Khan, Alexandros Tselis, Aaron Boster
Drugs|December 15, 2010
The potential role of B cell-targeted therapies in multiple sclerosisAaron Boster, Daniel P Ankeny, Michael K Racke
Therapeutic Advances in Neurological Disorders|October 20, 2011
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosisAaron Boster, Mary Pat Bartoszek, Colleen O'Connell, et al.
Journal of the International Neuropsychological Society : JINS|November 2, 2011
Physical activity associated with increased resting-state functional connectivity in multiple sclerosisRuchika Shaurya Prakash, Beth Patterson, Alisha Janssen, et al.
Journal of Clinical and Experimental Neuropsychology|April 8, 2015
The effects of video-game training on broad cognitive transfer in multiple sclerosis: A pilot randomized controlled trialAlisha Janssen, Aaron Boster, HyunKyu Lee, et al.
Neurology. Clinical Practice|February 15, 2018
Managing loss of intrathecal baclofen efficacy: Review of the literature and proposed troubleshooting algorithmAaron Boster, Jacqueline Nicholas, Mary Pat Bartoszek, et al.
Neurology. Clinical Practice|March 13, 2019
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologistEdward J Fox, Guy J Buckle, Barry Singer, et al.
Neuropsychologia|August 27, 2013
Resting-state functional connectivity in multiple sclerosis: an examination of group differences and individual differencesAlisha L Janssen, Aaron Boster, Beth A Patterson, et al.
The Lancet. Neurology|February 20, 2019
Intracerebral haemorrhage during alemtuzumab administrationChristina J Azevedo, Christen Kutz, Amy Dix, et al.
Pageof 3